semaglutide and cardiovascular 💉 The FDA has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) Semaglutide protects the heart beyond

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

Consumers Using Glp-1 Medications for Weight Loss Skew Younger and Higher Income, Numerator Reports

Retatrutide vs Tirzepatide Tirzepatide (Mounjaro/Zepbound) adds GIP receptor activation to GLP-1, representing an intermediate step between Semaglutide and Retatrutide

Population: 192,000 GLP-1 users across all indications 63 percent female

Nevertheless, the major role of astrocytes in regulating glutamatergic activity remains the clearance of synaptic glutamate and maintenance of the glutamateglutamine cycle, which are energetically costly [34, 102]

J., Herbath, M., Fabry, Z